PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Phenotype | C0852949|arterial disease |
| Sentences | 5 |
| PubMedID- 21256469 | Risk of death and myocardial infarction in patients with peripheral arterial disease undergoing percutaneous coronary intervention (from the national heart, lung and blood institute dynamic registry). |
| PubMedID- 22390680 | Hypertension, systolic blood pressure > 140 mm hg and/or diastolic blood pressure > 90 mmhg and/or treatment for hypertension; hypercholesterolemia, total cholesterol level > 5.2 mmol/l; established arterial disease, history of myocardial infarction, angina pectoris, ischemic cerebrovascular disease, ischemic peripheral arterial disease at baseline; score, systematic coronary risk evaluation calculated on 124 patients 40 to 65 years old; slicc, systemic lupus international collaborating clinics; pathologic urine, as defined by the systemic lupus activity measure (slam); om, overall mortality; cvm, cardiovascular mortality; n-vm, non-vascular mortality. |
| PubMedID- 24367790 | myocardial infarction (mi) resulting from coronary arterial disease is the number one cause for mortality in the united states. |
| PubMedID- 26496326 | A cardiovascular event was defined as a coronary arterial disease with angina, myocardial infarction, heart failure, or ventricular tachycardia/fibrillation documented in an emergent room (er) or upon admission by thallium scan or coronary angiogram. |
| PubMedID- 22431404 | Similar benefit is not seen after myocardial infarction or in patients with chronic arterial disease. |
Page: 1